Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Weed (BUDZ) EBIT (2017 - 2025)

Weed has reported EBIT over the past 12 years, most recently at -$1.9 million for Q4 2025.

  • For Q4 2025, EBIT fell 313.58% year-over-year to -$1.9 million; the TTM value through Dec 2025 reached -$2.5 million, down 601.29%, while the annual FY2025 figure was -$1.3 million, 360.17% down from the prior year.
  • EBIT for Q4 2025 was -$1.9 million at Weed, down from -$66897.0 in the prior quarter.
  • Over five years, EBIT peaked at $912847.0 in Q4 2024 and troughed at -$1.9 million in Q4 2025.
  • A 5-year average of -$341458.5 and a median of -$183908.0 in 2023 define the central range for EBIT.
  • Biggest five-year swings in EBIT: surged 2887.66% in 2024 and later tumbled 313.58% in 2025.
  • Year by year, EBIT stood at -$169910.0 in 2021, then crashed by 70.01% to -$288861.0 in 2022, then skyrocketed by 88.66% to -$32746.0 in 2023, then surged by 2887.66% to $912847.0 in 2024, then tumbled by 313.58% to -$1.9 million in 2025.
  • Business Quant data shows EBIT for BUDZ at -$1.9 million in Q4 2025, -$66897.0 in Q3 2025, and -$94045.0 in Q2 2025.